Fig. 1From: Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic miceIllustration of experimental protocols. STZ (60 mg/kg/d × 5 d, i.p.) was given to induce diabetes in C57BL/6 mice, and blood glucose was monitored. Metformin (250 mg/kg/d × 14 d, i.g.) was given for consecutive 14 days. Then wound healing, BM-EPC functions and proteins were measuredBack to article page